Drug intelligence / Profile preview

Blue Gorilla OG

Development stage: Unknown
Modality: Small Molecules
Administration: Inhalation, Oral

Overview

Blue Gorilla OG appears to be a **cannabis product or cultivar name rather than a conventional pharmaceutical drug**. Available source snippets describe it as a high-THC cannabis extract or shatter product and, in some listings, as a cannabis cultivar related to Blue Gorilla or Glueberry OG lineage. Reported lineage in retail and strain databases variably references combinations of **OG Kush**, **Gorilla Glue or GG4**, and **Blueberry**, indicating that the name is used in the commercial cannabis market without a single clearly standardized active pharmaceutical ingredient, developer, or mechanism beyond the general pharmacology of phytocannabinoids such as THC acting primarily at cannabinoid receptors.

Brand names: Blue Gorilla OG
Other names: Blue Gorilla

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Blue Gorilla OG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Gorilla OG.

Explore the full profile